SLV320

DRUG3 trials

Sponsors

Solvay Pharmaceuticals

Conditions

Acute Decompensated Heart Failure; Renal DysfunctionCongestive Heart Failure

Phase 2

Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

CompletedNCT00160134

Solvay PharmaceuticalsCongestive Heart Failure

Start: 2005-01-31Updated: 2009-01-30

Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

TerminatedNCT00744341

Solvay PharmaceuticalsAcute Decompensated Heart Failure; Renal Dysfunction

Start: 2009-02-28End: 2010-01-31Updated: 2010-09-17

Unknown Phase

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

TerminatedNCT00568009

Solvay PharmaceuticalsCongestive Heart Failure

Start: 2007-10-31End: 2008-11-30Target: 300Updated: 2008-04-22

Related Papers

Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.

2009-09-2424 citations